Lsv Asset Management Emergent Bio Solutions Inc. Transaction History

Lsv Asset Management

$45.3 Billion
Q3 2025

A detailed history of Lsv Asset Management transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Lsv Asset Management holds 864,500 shares of EBS stock, worth $8.74 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

864,500

Previous 815,591 6.0%

Holding current value

$8.74 Million

Previous $5.2 Million 46.55%

% of portfolio

0.02%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	BUY	$5.63 - $9.32 $275,357 - $455,831	48,909 Added 6.0%	864,500 $7.63 Million
Q2 2025 Aug 11, 2025	SELL	$4.26 - $6.94 $66,456 - $108,264	-15,600 Reduced 1.88%	815,591 $5.2 Million
Q1 2025 May 08, 2025	BUY	$4.66 - $11.66 $3.77 Million - $9.44 Million	809,591 Added 3748.11%	831,191 $4.04 Million
Q4 2024 Feb 13, 2025	BUY	$7.72 - $11.97 $166,752 - $258,552	21,600 New	21,600 $206,000
Q2 2023 Aug 02, 2023	SELL	$7.35 - $13.21 $224,733 - $403,908	-30,576 Reduced 42.9%	40,700 $299,000

Q1 2023 May 02, 2023	SELL	$7.79 - $16.29 $267,976 - $560,376	-34,400 Reduced 32.55%	71,276 $738,000
Q1 2022 May 12, 2022	BUY	$36.48 - $52.22 $518,015 - $741,524	14,200 Added 15.52%	105,676 $4.34 Million
Q4 2021 Jan 28, 2022	BUY	$33.11 - $55.01 $2.03 Million - $3.37 Million	61,176 Added 201.9%	91,476 $3.98 Million
Q1 2021 Apr 30, 2021	SELL	$86.23 - $125.19 $232,821 - $338,013	-2,700 Reduced 8.18%	30,300 $2.82 Million
Q4 2020 Feb 08, 2021	BUY	$79.17 - $111.47 $562,107 - $791,437	7,100 Added 27.41%	33,000 $2.96 Million
Q2 2020 Aug 05, 2020	SELL	$54.33 - $89.52 $249,918 - $411,792	-4,600 Reduced 15.08%	25,900 $2.05 Million
Q1 2020 May 07, 2020	BUY	$49.34 - $68.76 $1.5 Million - $2.1 Million	30,500 New	30,500 $1.76 Million
Q4 2018 Feb 05, 2019	SELL	$55.63 - $73.24 $984,651 - $1.3 Million	-17,700 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$52.05 - $66.51 $2.8 Million - $3.57 Million	-53,700 Reduced 75.21%	17,700 $1.17 Million
Q2 2018 Aug 08, 2018	SELL	$48.33 - $55.64 $6.97 Million - $8.02 Million	-144,200 Reduced 66.88%	71,400 $3.6 Million
Q1 2018 May 04, 2018	SELL	$44.44 - $54.39 $23.6 Million - $28.9 Million	-530,918 Reduced 71.12%	215,600 $11.4 Million
Q4 2017 Feb 01, 2018	BUY	$37.77 - $47.75 $3.44 Million - $4.34 Million	90,971 Added 13.88%	746,518 $0
Q3 2017 Nov 13, 2017	BUY	$34.14 - $40.45 $22.4 Million - $26.5 Million	655,547	655,547 $26.5 Million

Others Institutions Holding EBS

# of Institutions

191

Shares Held

41.3M

Call Options Held

899K

Put Options Held

256K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $504M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account

Lsv Asset Management Emergent Bio Solutions Inc. Transaction History